Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Neurobiological Findings of the Endocannabinoid System in Individuals with Social Anxiety Disorder and Healthy Controls: A Positron Emission Tomography Study
EF 2021-22
Résumé
Social Anxiety Disorder (SAD) is one of the most common mental health disorders in Canada. SAD is characterized by an intense, debilitating fear and/or avoidance of social situations. Currently available treatments for SAD include medications and psychotherapy, however, these treatments do not work for more than one third of patients.An emerging idea in the field of SAD research is that the brain system that responds to cannabis-like substances, called the endocannabinoid system (ECS), may be involved. Changes in the ECS have been linked to mental health conditions such as depression and anxiety. Brain imaging techniques, such as positron emission tomography (PET), can be used to visualize the activity of different biological systems in the brain to find new biological mechanisms and inform the development of new and more effective treatments. This ground-breaking study will use PET imaging to visualize the enzyme that regulates a substance within the ECS called anandamide (AEA). This enzyme is fatty acid amide hydrolase (FAAH), and it is thought to be elevated in individuals suffering from SAD. As such, blocking this enzyme to cause a natural increase in ESC activity has become a favorable therapeutic strategy. This study aims to help better understand the role of the ECS in SAD, visualize differences in FAAH levels in the brain of individuals with SAD and healthy individuals, and determine if FAAH levels in the brain are linked to severity of SAD. This study is clinically relevant, as the results will provide direct evidence on how the brain ECS is regulated in individuals with SAD. It will inform the development of novel and specific treatments targeting the ECS for patients suffering from this isolating and debilitating mental health condition.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
467047
Name
Pereira Christina F
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Neurobiological Findings of the Endocannabinoid System in Individuals with Social Anxiety Disorder and Healthy Controls: A Positron Emission Tomography Study
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Anxiety; Clinical Research; Endocannabinoid System; Fatty Acid Amide Hydrolase; Neuroimaging; Positron Emission Tomography; Psychiatry; Social Anxiety Disorder; Stress
Abstract
Social Anxiety Disorder (SAD) is one of the most common mental health disorders in Canada. SAD is characterized by an intense, debilitating fear and/or avoidance of social situations. Currently available treatments for SAD include medications and psychotherapy, however, these treatments do not work for more than one third of patients.An emerging idea in the field of SAD research is that the brain system that responds to cannabis-like substances, called the endocannabinoid system (ECS), may be involved. Changes in the ECS have been linked to mental health conditions such as depression and anxiety. Brain imaging techniques, such as positron emission tomography (PET), can be used to visualize the activity of different biological systems in the brain to find new biological mechanisms and inform the development of new and more effective treatments. This ground-breaking study will use PET imaging to visualize the enzyme that regulates a substance within the ECS called anandamide (AEA). This enzyme is fatty acid amide hydrolase (FAAH), and it is thought to be elevated in individuals suffering from SAD. As such, blocking this enzyme to cause a natural increase in ESC activity has become a favorable therapeutic strategy. This study aims to help better understand the role of the ECS in SAD, visualize differences in FAAH levels in the brain of individuals with SAD and healthy individuals, and determine if FAAH levels in the brain are linked to severity of SAD. This study is clinically relevant, as the results will provide direct evidence on how the brain ECS is regulated in individuals with SAD. It will inform the development of novel and specific treatments targeting the ECS for patients suffering from this isolating and debilitating mental health condition.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Pereira, Christina F
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~